PEPFAR实验室实施策略作为其五年战略的组成部分
本文介绍PEPFAR(美国总统艾滋病紧急救援计划)实验室实施策略。过去PEPFAR的实验室投资与伙伴国政府合作,显著提升了各国临床和公共卫生实验室能力,并在新冠和猴痘疫情中支持诊断开发。该策略基于「5×3」战略方法,旨在与各国政府合作,以整合方式维持HIV/AIDS成果并加强未来大流行防范。
要点
- PEPFAR实验室投资提升了伙伴国临床和公共卫生实验室整体能力。
- 现有PEPFAR支持的实验室系统在新冠和猴痘疫情中被用于支持诊断开发。
- 实验室实施策略基于「5×3」战略方法,支持国家公共卫生系统整合。
核心结论
- PEPFAR实验室实施策略指导如何利用「5×3」战略方法与国家政府合作,以整合方式维持HIV/AIDS成果并加强大流行防范能力。
研究设计与样本
- 本文为PEPFAR实验室实施策略的描述性文件,总结过去实验室投资影响并分享「5×3」战略方法的应用指导。
主要发现
- 过去PEPFAR实验室投资对各国整体临床和公共卫生实验室能力产生了根本性和实质性影响。
- PEPFAR支持的实验室系统在新冠和猴痘疫情中被用于支持诊断开发与实施,同时维持HIV和结核防治成果。
关键数值与推荐
- PEPFAR的5×3战略方法可用于与各国政府和其他全球卫生利益相关方密切合作。
- 策略强调以整合方式支持国家公共卫生系统,维持当前HIV/AIDS成果并加强本地能力。
临床怎么用
- 感染科医生可了解PEPFAR实验室策略通过整合方式支持国家公共卫生系统,以维持HIV/AIDS成果并加强大流行防范。
局限性
- 本文为策略描述,未报告具体研究设计、样本量或定量评估数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Past United States President's Emergency Plan for AIDS Relief (PEPFAR) laboratory investments for human immunodeficiency virus (HIV) epidemic response, in collaboration with partner governments and other stakeholders, have had a fundamental and substantial impact on overall clinical and public health laboratory capacity in countries. These innovations have been and continue to be leveraged to improve the functioning of entire health systems, including providing essential high-quality clinical diagnostics for multiple diseases and responding to outbreaks and pandemics. This was recently demonstrated in the coronavirus disease 2019 pandemic and mpox outbreaks, during which existing PEPFAR-supported laboratory systems were leveraged to support diagnostic development and implementation, while remaining focused on sustaining past HIV and tuberculosis gains. Building on these gains, the PEPFAR Laboratory Implementation Strategy shares guidance on how PEPFAR's 5 × 3 strategic approaches could be used to continue working closely with national governments and other global health stakeholders to support countries' national public health systems in an integrated manner to sustain current HIV/AIDS gains and strengthen local capacity in anticipation of future pandemic preparedness and response.
引用
- Alemnji G, Sangthong A, Espy N, et al. PEPFAR Laboratory Implementation Strategy as a Component of PEPFAR's 5-Year Strategy. J Infect Dis. 2025. PMID: 40976856. doi:10.1093/infdis/jiaf337
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。